BioMarin Pharmaceutical Inc. (VIE:BMRN)
Austria · Delayed Price · Currency is EUR 46.07
-0.16 (-0.35%)
Last updated: Dec 5, 2025, 3:30 PM CET
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of €8.87 billion as of December 5, 2025. Its market cap has decreased by -20.60% in one year.
Market Cap
8.87B
Enterprise Value
8.12B
Revenue
2.64B
Ranking
n/a
PE Ratio
19.99
Stock Price
€46.07
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 425.62M to 8.87B, an increase of 1,983.12%. That is a compound annual growth rate of 12.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 8.87B | -26.72% |
| Dec 31, 2024 | 12.10B | -26.36% |
| Dec 29, 2023 | 16.43B | -8.70% |
| Dec 30, 2022 | 18.00B | 26.18% |
| Dec 31, 2021 | 14.26B | 9.60% |
| Dec 31, 2020 | 13.01B | -3.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erste Group Bank AG | 37.86B |
| VERBUND AG | 21.89B |
| OMV Aktiengesellschaft | 15.70B |
| Raiffeisen Bank International AG | 11.72B |
| BAWAG Group AG | 9.06B |
| Strabag SE | 8.91B |
| Voestalpine AG | 6.43B |
| Vienna Insurance Group AG | 6.23B |